Detalhe da pesquisa
1.
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study.
Lancet Haematol
; 10(4): e272-e283, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990622
2.
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes.
J Clin Oncol
; 40(34): 3985-3993, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816664